Consistently, gut microbiota of individuals with MetS and with intestinal inflammatory disease showed decreased AHR activation (22, 47), suggesting that dysregulation of indole metabolites and AHR activation could be involved in inflammatory diseases. This evidence concerns the gene AHR and metabolic syndrome.